Navigation Links
Healionics Corporation Completes Series A Financing
Date:1/29/2008

REDMOND, Wash., Jan. 29 /PRNewswire/ -- Healionics Corporation, a provider of tissue regeneration and device biointegration solutions to healthcare manufacturers, today announced that it has raised $1.7 million in a Series A financing. The financing was led by individual investors including Carl Lombardi, former CEO of SpaceLabs Medical and Sam Naficy, M.D., Medical Director of Naficy Plastic Surgery & Rejuvenation Center.

"We are pleased to secure this financing, which provides recognition of our technology platform and allows Healionics to continue expanding the potential of STAR materials to enhance current and next generation medical devices," said Rob Brown, Chief Executive Officer of Healionics. "These funds will be used specifically to scale up the STAR material manufacturing process, to expand and accelerate preclinical studies of STAR materials and to advance our business development activities."

Healionics' propriety STAR Material -- Sphere Templated Angiogenic Regenerative Material -- is specifically engineered to enhance biointegration and promote healing. Described as the 'Gore-Tex(TM) of biomaterials,' STAR is designed to enable the biocompatibility of a wide range of medical devices that are implanted into the body.

"Healionics has a very promising technology that offers widespread opportunities in a rapidly expanding cosmetic market," said Sam Naficy, M.D. "It is this versatility and expansiveness that make Healionics a very attractive business model, and I look forward to the future advancement of this Company."

Healionics was formed in March 2007. To date, Healionics has entered into multiple agreements for the advancement of its STAR(TM) material into various market applications including diabetes, wound care and infusion therapy.

About Healionics Corporation

Healionics is a privately held biomaterials company whose mission is to be the leading partner of tissue regeneration and device biointegration solutions to healthcare manufacturers. Healionics has licensed STAR Material -- Sphere Templated Angiogenic Regenerative Material -- that works with the body to promote healing and enables the biocompatibility of a wide range of medical devices that are implanted into the body. Healionics was voted the Best Technology Investment Opportunity at the Zino Society's 2007 Zillionaire Investment Forum and was recently named "Most Promising New Biotech Firm of 2007" by Seattle Business Monthly. Healionics will debut its technology as an exhibitor (booth #790) at the Medical Design & Manufacturing West (MD&M West) 2008 conference, Jan. 29-31 in Anaheim, Calif. Healionics Corporation is headquartered in Redmond, Washington. For more information, please visit http://www.healionics.com.

Contact:

Julie Rathbun

Rathbun Communications, Inc.

(206) 769-9219

Julie@rathbuncomm.com


'/>"/>
SOURCE Healionics Corporation
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Healionics Corporation Announces Partnership to Develop and Distribute STARcuff(TM)
2. Memry Corporation Announces Preliminary Fiscal Fourth Quarter and 2007 Revenue
3. PeriCor Therapeutics Announces Closing of Licensing Agreement for Acadesine with Schering-Plough Corporation
4. AGA Medical Corporation Receives FDA and CE Mark Approvals for the AMPLATZER Vascular Plug II
5. Drug Royalty Corporation (DRC) Announces Acquisition Regarding PEG-INTRON(R) From Enzon Pharmaceuticals, Inc. (ENZN)
6. BioElectronics Corporation Announces Singapore and Malaysia Sales
7. Avicena Signs Worldwide Exclusive Distribution Agreement with RITA Corporation for its Proprietary Dermaceutical Compounds
8. DURECT Corporation to Present at the NewsMakers in the Biotech Industry Investment Conference
9. Insulet Corporation to Present at the Thomas Weisel Partners Healthcare Conference on September 6, 2007
10. Luminex Corporation to Present at Thomas Weisel Partners Healthcare Conference
11. Verenium Corporation to Present at the Upcoming Cowen and Company Clean Energy Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2017)... ... June 27, 2017 , ... Indiana-based Xylogenics announced today ... and fermentation process. The efficiencies created by the newest strain design will ... the ethanol industry wherein individual production plants are planning to invest upwards of ...
(Date:6/26/2017)... ... June 26, 2017 , ... ... the former Associate Director of Product Development R&D at Allergan and CMC expert ... at both start-up and established biopharma companies, has joined the firm as an ...
(Date:6/26/2017)... ... June 26, 2017 , ... The Workgroup for ... health IT to create efficiencies in healthcare information exchange and a statutory advisor to ... MD, head of the federal Office of the National Coordinator for Health Information Technology, ...
(Date:6/23/2017)... , ... June 23, 2017 , ... Biova, LLC., the ... has joined Biova’s Board of Directors. Dr. Henig will bring a wealth of scientific ... has served as the Chief Technical and Scientific Officer of four major global companies ...
Breaking Biology Technology:
(Date:4/5/2017)... Allen Institute for Cell Science today announces the launch ... dynamic digital window into the human cell. The website ... deep learning to create predictive models of cell organization, ... suite of powerful tools. The Allen Cell Explorer will ... resources created and shared by the Allen Institute for ...
(Date:4/4/2017)... April 4, 2017   EyeLock LLC , a ... the United States Patent and Trademark Office (USPTO) has ... the linking of an iris image with a face ... represents the company,s 45 th issued patent. ... very timely given the multi-modal biometric capabilities that have ...
(Date:3/30/2017)... , March 30, 2017 The research ... system for three-dimensional (3D) fingerprint identification by adopting ground breaking 3D ... a new realm of speed and accuracy for use in identification, ... an affordable cost. ... ...
Breaking Biology News(10 mins):